Conférences  >  Médecine & Soins de Santé  >  Pharmacologie et développement des médicaments  >  Allemagne

Veridon Global Pvt Ltd

The EuroPotent Therapeutics Summit, hosted by Veridon Global is set to convene leading experts, innovators, and decision-makers in the field of high-potency active pharmaceutical ingredients (HPAPI) and potent therapeutic development. It will take place on 22nd-23rd May 2025 in Frankfurt, Germany, offering an unparalleled platform for professionals in the pharmaceutical and biotech sectors to explore the latest developments in HPAPI. With Europe at the forefront of global regulatory standards, this summit will provide a comprehensive overview of the evolving regulatory landscape, with a focus on compliance challenges, emerging technologies, and cutting-edge safety practices specific to HPAPI manufacturing. Key themes will include advancements in containment and isolation technologies, environmental sustainability, and the integration of digital tools to optimize production processes while ensuring safety and regulatory adherence.

Tél.: [+1 6672600490];     Email.: marketing@veridonglobal.com

EuroPotent Therapeutics Summit, EuroPotent Therapeutics Conference, EuroPotent Therapeutics, Pharma conference in Europe, high-potency active pharmaceutical ingredients, HPAPI, HPAPI development, HPAPI manufacturing, drug development

Veridon Global Pvt Ltd

Veridon Global is proud to present the EVIDENCE 360: RWE, Pricing & Reimbursement Summit Europe on 26th-27th May 2025 in Frankfurt, Germany. This two-day summit is a must-attend event for healthcare professionals, pharmaceutical leaders, policymakers, and researchers, offering an in-depth exploration of the latest trends, challenges, and innovations in Real-World Evidence (RWE), pricing strategies, and reimbursement frameworks in Europe.

As the healthcare landscape evolves, RWE is becoming increasingly vital for decision-making, influencing how drugs are priced, reimbursed, and integrated into healthcare systems. This summit will address the current challenges in RWE adoption, including the complexities of data quality, integration of electronic health records, addressing key topics such as the integration of RWE into pricing strategies, the alignment of RWE with health technology assessments (HTAs), and the complexities surrounding cross-border reimbursement policies. Attendees will gain valuable insights into the evolving role of RWE in shaping pricing models and market access strategies within the European context, focusing on how healthcare systems are evolving to incorporate this data for more value-based and patient-centric decisions.

Tél.: [+1 6672600490];     Email.: marketing@veridonglobal.com

EVIDENCE 360, EVIDENCE 360 summit, Real-World Evidence, Real-World Evidence trends, Real-World Evidence summit, Real-World Evidence conference in Europe,